mercredi 22 juin 2016

Onco Actu du 22 juin 2016

2.5 Etiologie - Gènes

Landmark study gives clearest picture of genetic causes of bowel cancer [The Institute of Cancer Research]

3.4 Chimioprévention

Lab study ‘sheds new light’ on BRCA-linked breast cancer [Cancer Research UK]

4. Dépistage, diagnostic et pronostic

Study finds patient navigators improve comprehensive cancer screening rates [Massachusetts General Hospital]

5. Traitements

Watch our Google Hangout about drug discovery and making new medicines (Part 1 of 2) [Cancer Research UK]

5.12 Immunothérapies

Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial [Xconomy]

First proposed human test of CRISPR passes initial safety review [Science]

Federal advisory committee greenlights first CRISPR clinical trial [Nature News & Comment]

5.4 Traitements - Economie

Nice backs two cancer drugs from Novartis [Pharmafile]

Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer [NICE]

More health plans want to pay for drugs based on patient outcomes [STAT]

6. Lutte contre les cancers

The ups and downs of data sharing in science [Nature News & Comment]

6.10 Politiques

Landmark effort to speed drug approvals nears critical phase in Congress [STAT]

6.6 Publications

Highly cited cancer researcher logs 8th, 9th retractions [Retraction Watch]

6.7 DMP, Big Data & applis

Making NHS data public is not the same as making it accessible – we can and should do better [The Guardian]

6.8 Communication

Patient anecdotes as a public relations tool [HealthNewsReview]

6.9 Controverses

Clinical Research’s Flaws Highlighted By Stanford’s John Ioannidis [Scope Blog]